OAKLAND – Although the company will continue development work on Clorox nasal spray, coffee pods, and edibles, the end to President Trump’s daily briefings has prompted Clorox (CLX) executives to announce a downward revision in guidance for the second quarter. Clorox had seen a welcome swell in business during the coronavirus pandemic that was further augmented by the President seemingly suggesting that Americans drink bleach. “We would like to thank the President for his support,” CEO Benno Dorer stated during the guidance revision, “and for his brilliant ideas that have accelerated [Clorox’s] pace of research and development many years, if not decades.” Dorer pointed to significant progress toward turning the active ingredient of Clorox bleach, sodium hypochlorite, into a fine mist for inhaling. “With the possible cessation of the daily coronavirus briefings, however, we lose both a great inspiration and a direct marketing pathway into the homes of the American public.” Investors reacted poorly to the bad news, pushing Clorox (CLX) stock to all-time highs.

Img src: https://www.flickr.com/photos/jeepersmedia/15017661298